Molecular Design and the Critical Path Problem
In this episode, Dr. Stephen Byrn, Head of Aptuit Scientific Advisory Board, speaks about the critical path problem in drug development and how a desi...
Issues and Innovations in Drug Development presented by Aptuit
Share:
Listens: 3
About
Thank you for subscribing to our podcast series. Aptuit will continually update the series with interviews from experts across the entire drug development continuum.
Redefining the CRO
In this episode, Bob Burford Ph.D., Managing Director, Aptuit Consulting discusses the relationship between drug developers and CROs, including curren...
Informatics and clinical supply chain management: A stronger link for the drug development
In this installment of the series, Doug Meyer, Senior Director for Aptuit Informatics, discusses the role and importance of informatics in today’s cli...